Chinese herbology
traditional Chinese herbal therapy
Chinese herbology or Chinese materia medica (traditional Chinese: 中藥學; simplified Chinese: 中药学; pinyin: zhōngyào xué; lit. 'Chinese medication study') is the theory of traditional Chinese pharmacotherapy, which accounts for the majority of treatments in traditional Chinese medicine (TCM). It is analogous to other traditional materia medica systems.
The term herbology is misleading in the sense that, while plant elements are by far the most commonly used substances, animal, human, and mineral products are also used, some of which are poisonous. In the Huangdi Neijing they are referred to as 毒藥 (pinyin: dúyào) which means "poison-medicine". Paul U. Unschuld points out that this is similar etymology to the Greek pharmakon and so he uses the term pharmaceutic. Thus, the term medicinal (instead of herb) is usually preferred as a translation for 藥 (pinyin: yào).
A Nature editorial described TCM as "fraught with pseudoscience", and said that the most obvious reason why it has not delivered many cures is that the majority of its treatments have no logical mechanism of action. Research into the effectiveness of traditional Chinese medicinal therapy is of poor quality and often tainted by bias, with little or no rigorous evidence of efficacy. There are concerns over a number of potentially toxic Chinese medicinals, including Aristolochia which is thought to cause cancer.
Begin with the source’s own compact description: “Chinese herbology” is traditional Chinese herbal therapy. The dossier treats that line as a proposition to test through Chinese, herbology and traditional, not as a finished interpretation.
Why this record matters
The phrase “traditional Chinese herbal therapy” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
Named sources, stable identifiers and responsible institutions provide the strongest route from overview to verifiable evidence. The source revision retrieved here is dated Sep 20, 2026. The linked authority identifier is Q261503. None of the 0 selected statements returned an explicit reference.
The absence of detail may reflect summary conventions rather than a lack of surviving documentation. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Use the entry as an orientation point, then follow its citations and revision history. Names, dates and institutional relationships should be checked against the original record.
- Subject orientation
- Search vocabulary
- Locating named sources
The closest primary source, responsible institution and strongest cited specialist reference.
Three-step research path
- Establish the record: confirm the title “Chinese herbology”, its source revision and the description used here.
- Expand the search: follow Chinese herbology primary sources, Chinese herbology archive and Chinese research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “Chinese herbology”?
- Which institution is responsible for the underlying evidence?
- Which cited source is closest to the event, object or claim?
Search terms from this dossier
This entry incorporates text from “Chinese herbology” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.